openPR Logo
Press release

Asia-Pacific OTC Drugs Market: Analysis Report, Share, Trends and Overview 2021-2027

11-29-2021 05:17 PM CET | Health & Medicine

Press release from: Orion Market Research

The Asia-Pacific OTC drugs market is anticipated to grow at a CAGR of 7.9% during the forecast period. The market growth is attributed to the increasing trend of self-medication in the region coupled with the increasing healthcare spending. Major economies covered in the study of the Asia-Pacific OTC drugs industry report covers the analysis of China, Japan, India, and Rest of Asia-Pacific. Among these, India is an emerging region in the OTC drug landscape. Some of the major players in the OTC drug industry in India include Cipla, Dabur, Emami, GlaxoSmithKline, Piramal, and others.

A full report of Asia-Pacific OTC Drugs Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-over-the-counter-otc-drugs-market

Moreover, the Indian government is showing a keen interest in the growth of the Indian pharmaceutical sector among the other countries. The initiatives by the government such as Pharma Vision 2020, National Biopharma Mission, and National Health Policy schemes are driving the OTC drugs industry.

Some of the key driving factors for the growth of the Indian OTC drugs industry are as follows:

• The rapid shift from Rx to OTC
• Rise in the geriatric population.
• The shift in consumer preference towards self- medication.
• Affordability of OTC drugs.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-over-the-counter-otc-drugs-market

Market Coverage

• Market numbers available for – 2018-2025
• Base year- 2018
• Forecast period- 2019-2025
• Segment Covered-
o By Product Type
o By Distribution Channel
• Countries Covered-
o China
o India
o Japan
o Rest of Asia-Pacific
• Competitive Landscape- Cipla Ltd., The Piramal Group, Novartis International AG, Dabur India Ltd., Johnson & Johnson Services Inc., Teva Pharmaceuticals Industries. Ltd., and Takeda Pharmaceuticals Co. Ltd.

Key Questions Addressed by the Report

• What is the current market size and growth rate in the forecast period?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• Impact on market growth due to the COVID-19 pandemic?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/asia-pacific-over-the-counter-otc-drugs-market

Asia-Pacific OTC Drugs Market Report Segment

By Product Type

• Analgesics & Pain Relievers
• Cough, Cold & Flu Products
• Vitamins & Mineral Supplements
• Ophthalmic Products
• Others

By Distribution Channel

• Retail & Supermarket
• Online Platform

Company Profiles

• Cipla Ltd.
• Dabur India Limited
• Emami Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson Services Inc.
• Novartis International AG
• Sun Pharmaceuticals Ltd.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• The Piramal Group
• The Procter & Gamble Co.

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia-Pacific OTC Drugs Market: Analysis Report, Share, Trends and Overview 2021-2027 here

News-ID: 2478494 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to